Skip to main content

jacek hawiger Archives

Study reveals genomic code for sepsis in the lungs and kidneys

Aug. 21, 2023—Researchers at Vanderbilt University Medical Center and the Nashville Veterans Affairs Medical Center have “cracked” the genomic code for sepsis in the lungs and kidneys.

Read more


Hawiger still blazing a trail in inflammation research

Nov. 10, 2022—Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema.

Read more


Former Karolinska Institute chair Norrby set for March 14 lecture

Mar. 8, 2022—Erling Norrby, MD, PhD, a world authority on viruses and former chair at the Karolinska Institute in Stockholm, Sweden, will deliver a lecture at Vanderbilt University Medical Center on Monday, March 14.

Read more


VUMC team develops potential treatment for life-threatening microbial inflammation

Jun. 8, 2021—A cell-penetrating peptide developed by researchers at Vanderbilt University Medical Center can prevent, in an animal model, the often-fatal septic shock that can result from bacterial and viral infections.

Read more


Protein study may be key to treating fibrotic diseases

Jul. 30, 2020—A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.

Read more


Endotoxin shock protector

Nov. 5, 2019—A novel tool developed by Vanderbilt scientists protects animals from endotoxin shock and can be used for mechanistic analyses of inflammation due to microbial and other insults.

Read more


Faculty meeting recognizes excellence in education, research and clinical service

May. 24, 2018—During Wednesday’s Spring Faculty Meeting, Jeff Balser, M.D., Ph.D., dean of Vanderbilt University School of Medicine and President and CEO of Vanderbilt University Medical Center, highlighted the medical school’s rising stature among the country’s top-tier institutions.

Read more


VU scientists report a way to calm the sepsis “storm”

Jun. 22, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have found a way to calm the “genomic storm” that triggers the often-lethal consequences of sepsis.

Read more


Veterans Affairs Research Conference

Jun. 1, 2017—The 3rd National Veterans Health Affairs Research Conference held at Vanderbilt University Medical Center May 17-18.

Read more


Protecting the blood-brain barrier

Dec. 9, 2016—Vanderbilt investigators have discovered how a promising cancer immunotherapy causes brain swelling, findings that could lead to ways to protect brain function while fighting cancers.

Read more


Nine Vanderbilt faculty members elected AAAS fellows

Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Read more


Peptide quells “genomic storm”

Oct. 28, 2014—A cell-penetrating peptide developed at Vanderbilt blocks the signaling pathways that lead to lethal shock caused by bacterial infection.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more